GLOW Research Peptide Blend is a proprietary tri-peptide research blend formulated by AxonChems, combining three extensively studied research compounds — GHK-Cu (Copper Tripeptide-1), TB-500 (Thymosin Beta-4 fragment), and BPC-157 (Body Protection Compound-15) — in a single lyophilized vial for in-vitro laboratory research applications.
GHK-Cu is a naturally occurring tripeptide-copper complex (Glycyl-L-Histidyl-L-Lysine · Cu²⁺) with a molecular weight of approximately 403.93 g/mol. First isolated from human plasma, GHK-Cu has been the subject of extensive published research examining its copper ion delivery properties and interactions with extracellular matrix components in cell culture systems.
TB-500 is a synthetic peptide corresponding to the active region of Thymosin Beta-4, a 43-amino acid protein with a molecular weight of approximately 4963 g/mol. Published research has documented TB-500’s molecular interactions with G-actin and its role in actin polymerization dynamics in controlled in-vitro experimental models.
BPC-157 is a synthetic pentadecapeptide composed of 15 amino acids with a molecular weight of approximately 1419.53 g/mol, derived from a partial sequence of a naturally occurring gastric protein. BPC-157 appears in numerous peer-reviewed publications investigating its molecular interactions with nitric oxide signaling systems and growth factor receptor pathways in laboratory environments.
The GLOW blend is designed for researchers investigating the combined activity profiles of these three peptides without the need for individual sourcing, reconstitution, and mixing. The formulation ratios are optimized based on concentrations commonly referenced in published in-vitro research protocols examining multi-peptide signaling interactions.
